MedPath

Blood pressure monitoring in hypertensive antenatal women

Completed
Conditions
Gestational [pregnancy-induced] hypertension without significant proteinuria, third trimester,
Registration Number
CTRI/2022/09/045801
Lead Sponsor
Department of obstetrics and gynaecology LHMC
Brief Summary

**HYPOTHESIS**

Home blood pressuremonitoring is a effective modality for optimum blood pressurecontrol in women with hypertensive disorders of pregnancy.

  **AIM**

To study the performance of home blood pressure monitoring for optimum blood pressure controlin women with hypertensivedisorders of pregnancy.

  **OBJECTIVES**

Primary Objective-

 Â·        To compare the average BP records in women with HDP on homeblood pressure monitoring and on standard care

·        To determine adherence\* to home blood pressuremonitoring in women with HDP

Secondary Objective

·        To compare the usage of health resources by women on homeblood pressure monitoring and those on standard care.( hospitaladmissions and hospital stay of mother)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
170
Inclusion Criteria
  • Antenatal women between 32-36 weeks gestation diagnosed as having chronic or gestational hypertension Women having systolic blood pressure range 140-150 mmHg or diastolic BP range 90-100 mm Hg Cases of chronic or gestational HTN with systolic BP <150 mmHg or diastolic BP <100 mmHg with or without drugs.
  • Women willing to do BP monitoring by themselves and by clinician.
Exclusion Criteria

•Women with diagnosed Preeclampsia •Ultrasound showing fetal growth restriction with absent or reverse end diastolic flow on Doppler.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The mean BP of women with HBPM and those on standard careEvery one week till delivery
Proportion of women requiring intervention in cases and control.Every one week till delivery
Proportion of women on HBPM having mean blood pressureEvery one week till delivery
135/85, 135-150/85-100,more than 150/100 compared to controlsEvery one week till delivery
Proportion of women showing adherance.Every one week till delivery
Secondary Outcome Measures
NameTimeMethod
Duration of stay in hospital among study subjectsProportion of women having adverse maternal outcome

Trial Locations

Locations (1)

Lady hardinge medical college Delhi

🇮🇳

Central, DELHI, India

Lady hardinge medical college Delhi
🇮🇳Central, DELHI, India
Dr Bhawana Meena
Principal investigator
7838860131
bhawanameena1001@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.